Bottom line
How has SJVAX performed?
As of Dec 31, 2025, SJVAX returned +6.7% over the past year. Its best quarter was +14.9% and its worst −13.3%.
Updated Dec 31, 2025
SJVAX annual returns by year
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| SJVAX | +21.2% | +13.3% | −8.8% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in SJVAX
$10,000 invested at the start of 2022 would have been worth about $12,500 by the end of 2024, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2024 | +21.2% | $12,518 |
| 2023 | +13.3% | $10,329 |
| 2022 | −8.8% | $9,117 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| SJVAX | +6.7% | — | — | +7.4% |
| Large Value median | +13.6% | +11.3% | +10.2% | — |
Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jul 31, 2026, SJVAX returned +4.27%, +0.69%, +4.51% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.